Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Phaarmasia Limited (PHRMASI.BO)

Compare
27.60
+0.10
+(0.36%)
At close: 3:15:01 PM GMT+5:30
Loading Chart for PHRMASI.BO
  • Previous Close 27.50
  • Open 27.50
  • Bid 27.60 x --
  • Ask --
  • Day's Range 27.50 - 27.60
  • 52 Week Range 23.60 - 50.39
  • Volume 51
  • Avg. Volume 755
  • Market Cap (intraday) 188.424M
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.85
  • Earnings Date May 23, 2025 - May 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. The company offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, and stanozolol cypionate injections. It provides herbal products, such as herbal toothpaste, cough and sore throat reliver, and mouth ulcer gel under the Smyle brand name. Phaarmasia Limited was incorporated in 1981 and is based in Hyderabad, India.

www.phaarmasia.in

35

Full Time Employees

March 31

Fiscal Year Ends

Recent News: PHRMASI.BO

View More

Performance Overview: PHRMASI.BO

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

PHRMASI.BO
43.09%
S&P BSE SENSEX (^BSESN)
1.40%

1-Year Return

PHRMASI.BO
43.80%
S&P BSE SENSEX (^BSESN)
5.62%

3-Year Return

PHRMASI.BO
43.80%
S&P BSE SENSEX (^BSESN)
32.06%

5-Year Return

PHRMASI.BO
43.80%
S&P BSE SENSEX (^BSESN)
151.76%

Compare To: PHRMASI.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHRMASI.BO

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    187.74M

  • Enterprise Value

    184.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.65

  • Price/Book (mrq)

    1.89

  • Enterprise Value/Revenue

    0.64

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.01%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    289.28M

  • Net Income Avi to Common (ttm)

    -5.82M

  • Diluted EPS (ttm)

    -0.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.8M

  • Total Debt/Equity (mrq)

    0.82%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PHRMASI.BO

View More

Company Insights: PHRMASI.BO

Research Reports: PHRMASI.BO

View More

People Also Watch